To use factor analysis to examine the putative role of leptin in the Metabolic Syndrome, and to de®ne better the associations among observed variables and the identi®ed factors. DESIGN: Factor analysis of cross-sectional data from a 1987 survey. SUBJECTS: Non-diabetic residents of Mauritius who participated in population-based surveys in 1987 and 1992 (1414 men and 1654 women). MEASUREMENTS: Fasting and 2 h plasma glucose and insulin following a 75 g oral glucose load; seated blood pressure; body mass index (BMI); waist-to-hip ratio (WHR); and fasting serum triglycerides, HDL-cholesterol, leptin and uric acid concentrations. RESULTS: Principal components factor analysis revealed three factors for men and women that explained between 54 and 55% of the observed variance of the 12 measured variables. General features of these factors were as follows: factor 1, WHR, BMI, leptin, fasting and 2 h insulin, triglycerides, and HDL-cholesterol; factor 2, systolic and diastolic blood pressure, uric acid (men only), and fasting glucose (women only); and factor 3, fasting and 2 h glucose and insulin. Only three variables loaded on more than one factor with a loading !0.4 (fasting and 2 h insulin, fasting glucose in women only). Leptin loaded on one factor only in both men and women. CONCLUSIONS: Since multiple factors underlie the Metabolic Syndrome, and since no observed variable loads on all three factors, more than one mechanism might account for the observed clustering of risk characteristics. Leptin does not unite features of this syndrome due to its loading on one factor only. Uric acid is related to a different factor in men and women. The absence of gender differences in factor loadings argues for similar mechanisms for the Metabolic Syndrome in men and women in Mauritius.
Introduction
The association of insulin resistanceahyperinsulinaemia, overall and central obesity, glucose intolerance, dyslipidaemia (higher triglycerides and lower HDL-cholesterol) and hypertension, variously known as the Metabolic Syndrome, Syndrome X, or the Insulin Resistance Syndrome, has been observed in a number of populations. 1 Hyperuricaemia, and microalbuminuria are sometimes included in the syndrome. 2 It is generally believed that hyperinsulinaemia andaor insulin resistance underlie this clustering. 1 Leptin, the product of the ob gene, has been observed to be closely correlated with insulin levels, independently of obesity, in a range of populations; 3 and in a study of Polynesian Samoans was also independently associated with key variables of the Metabolic Syndrome. 4 These observations prompted the suggestion that leptin may underlie the Metabolic Syndrome, or at least be an additional component. 4 Studies in animals and in vitro investigations in humans have suggested that leptin may be related to insulin resistance, changes in insulin resistance, changes in insulin secretion, and potentially be a contributor to the development of diabetes. 5 ± 11 Thus while it is not clear from these data whether leptin is positively or negatively related to glucose tolerance, and how this association would be confounded by obesity, it seems that leptin might be linked with components of the Metabolic Syndrome.
Different statistical techniques have been used to examine the associations between variables of the Metabolic Syndrome. Factor analysis is one such approach that groups quantitatively measured variables into clusters known as factors', based on the correlations between the variables. 12 A recently published study using factor analysis concluded that leptin was strongly related to the principal components of the insulin resistance syndrome and proposed the existence of an insulin ± leptin axis underlying this Syndrome. 13 However, leptin was only strongly correlated with the ®rst of three factors, which included insulin sensitivity measures, was weakly correlated with an obesity and blood pressure factor, and not at all correlated with a dyslipidaemia factor. 13 We have now used factor analysis to examine the putative role of leptin in the Metabolic Syndrome among Mauritians. If leptin underlies the Metabolic Syndrome, it should occur in all factors identi®ed.
Subjects and methods

Subjects
The subjects were drawn from a population-based noncommunicable disease survey performed in Mauritius in 1987 and are described in detail elsewhere. 14, 15 Mauritius is an island nation located in the southwestern Indian Ocean. The multiethnic population comprises about 70% Asian Indian origin, 27.9% Creole (mixed with mainly African ancestry) and 2.1% Chinese. The survey protocol was reviewed and approved by the Alfred Healthcare Group Ethics Committee (Melbourne, Australia).
Survey procedure and analyses
All adults aged 25 ± 74 y were eligible to attend the survey if resident in the population clusters chosen in the representative sample.
14 Subjects presented to a survey site between 08:00 and 10:00 h after an overnight fast. All subjects not using oral hypoglycaemic tablets or insulin underwent an oral glucose tolerance test (75 g dextrose monohydrate). Fasting and 2 h blood samples were collected and plasma glucose was measured on-site using a glucose analyser (YSI, Yellow Springs, Ohio). Glucose tolerance status was classi®ed according to WHO recommendations. 16 Body mass index (BMI) was calculated as kgam 2 and waist and hip girth were measured in duplicate to calculate waista hip ratio (WHR) from the means of measurements as previously described. 14 Eligibility for the present study was limited to 1414 men and 1654 women who were non-diabetic (normal and impaired glucose tolerance) in 1987, and who also attended a follow-up survey in 1992, as leptin measurements were only done on sera frozen since 1987 (À20 C) in subjects who attended both surveys. People with diabetes were excluded, consistent with the previous analyses. 17, 18 because diabetes is considered to be a consequence of, rather than a feature of, the Metabolic Syndrome. 17, 19 Leptin assays were performed in 1996 using radioimmunoassay kits (Linco, St Louis, MO, USA). Insulin values for the same subjects were measured in 1987 on frozen sera using an in-house assay. 20, 21 Interassay and intraassay coef®cients of variation were 6% and 4%, respectively. Cross-reactivity with intact proinsulin and 32, 33-split proinsulin was 27% and 16%, respectively. There was less than 5% difference between results obtained with this assay and a highly speci®c enzyme-linked immunosorbent assay. Serum uric acid, fasting triglycerides and HDL-cholesterol were measured using manual enzymatic methods at the central laboratory in Mauritius.
Statistical analysis
Statistical analysis was performed using SPSS for Windows Release 9.0.1. Factor analysis consists of three steps: computation of a correlation matrix for all variables included; factor extraction; and orthogonal rotation to make factors more readily interpretable. Factors were extracted by principal component analysis, in which linear combinations of the variables are formed, with the ®rst principal component accounting for the largest amount of variance in the sample. The components are all uncorrelated. Factor loadings, equivalent to a Pearson's correlation coef®cient between each variable and the factor, are used to interpret which variables are included in each factor. Variables with factor loadings of at least 0.3 have generally been considered to be included, although it is suggested that only loadings greater than or equal to 0.4, which therefore share at least 15% of variance with the factor, should be used in interpretation. 12 A factor loading with an absolute value of 0.4 or greater has been used for this analysis. Factors were selected such that each explained at least as much (eigenvalue !1) or nearly as much variance as any one observed variable (eigenvalue 1 by de®nition). In addition, we required that each factor have more than two variables with loadings !|0.4|. Table 1 shows the mean values of the Metabolic Syndrome variables in the men and women included in this analysis. On average, subjects were 41 y old and non-obese, with mean BMI values below 25. The mean serum leptin concentration in women was about three times that in men, despite a difference of only about 1 kgam 2 on average in BMI. Variables tended to be moderately to strongly correlated with each other, as required for factor analysis ( Table 2) . Exceptions occurred for high-density lipoprotein (HDL)-cholesterol with blood pressure, fasting glucose with 2 h insulin in women and with HDL-cholesterol in men, and Leptin and the Metabolic Syndrome AM Hodge et al uric acid with fasting glucose and HDL-cholesterol in men. Leptin was signi®cantly correlated with all the other variables (P`0.001), although some of the correlation coef®-cients were relatively small.
Results
The number and characteristics of factors identi®ed in men and women were very similar (Table 3 ). Using our criteria for selecting factors, we identi®ed three for both men and women that accounted for a similar proportion of variance (54 ± 55%). The ®rst factor was characterized by positive loadings for fasting and 2 h insulin, WHR, BMI, triglycerides and leptin and a negative loading for HDLcholesterol in men and women, and uric acid in women only. High blood pressure loading characterized the second factor, with fasting glucose loading on this factor among women and uric acid among men. Glucose intolerance and When the criterion for factor extraction was set at an eigenvalue b1.0 and no limitation on the number of variables with loadings !|0.4|, a different number of factors was identi®ed for men (n 3) compared to women (n 4) ( Table  3 ). The four-factor model in women accounted for a larger proportion of variance than the three-factor model in men or women (62% vs 54 ± 55%). The four-factor model in women was characterized by a dyslipidaemia factor (factor 4) separate from factor 1 in the three-factor model. Factors 2 and 3 in this four-factor model in women were similar to those in the three-factor model with regard to the speci®c variables with loadings !|0.4|.
Factors were also computed within age ( 45 or b45 y) and ethnicity (Indian or Creole) strata. Chinese were not analysed separately due to limited numbers. These analyses did not suggest any major differences between age or ethnic groups (data not shown).
Discussion
Leptin, a strong correlate of insulin level and obesity, 3 was highly correlated with only one of three identi®ed factors in this analysis. This factor was characterized mainly by high loadings for overall adiposity (BMI), greater central body fat distribution (WHR), hyperinsulinaemia, triglycerides and HDL-cholesterol. Thus leptin played a role in this obesity ± insulin resistance factor, but did not overlap with glucose intolerance or blood pressure factors, arguing that in this population it was not an underlying feature of the Metabolic Syndrome, despite the evidence for its effects on insulin and glucose tolerance. 5 ± 11,22,23 A factor analysis conducted among 74 nondiabetic men considered leptin along with Metabolic Syndrome features, including uric acid. 13 Three factors were identi®ed, an insulin resistance factor on which leptin loaded, a dyslipidaemia factor, and a factor combining glucose intolerance, central obesity, high blood pressure and elevated serum uric acid. If no adjustment was made for BMI, leptin was also included in the glucose intolerance factor. The factors identi®ed by Leyva et al 13 are not similar to those seen in our analysis, although in both cases leptin was included with markers of insulin resistance and hyperinsulinaemia. The authors concluded that insulin and leptin together might be important in coordinating the disturbances of the Metabolic Syndrome. 13 The importance of leptin in the Metabolic Syndrome has been explored in other studies using alternative analyses. In a case ± control study of men in the Quebec Cardiovascular Study cohort, leptin was correlated with triglycerides and insulin, but not total cholesterol, HDL-cholesterol, totalaHDL-cholesterol ratio or apolipoprotein B and was not a predictor of ischaemic heart disease. 24 One prospective study has identi®ed high leptin level as a risk factor for the development of type 2 diabetes among Japanese-American men. 25 This analysis con®rms the general ®ndings from other factor analyses of the Metabolic Syndrome that have identi®ed between two and four factors. Our results for the threefactor model are generally similar to those found in the Framingham population as described by Meigs et al, 17 with an impaired glucose tolerance factor (factor 3, Table 3 ), a hypertension factor (factor 2, Table 3 ), and a central Metabolic Syndrome factor (hyperinsulinaemia, obesity, dyslipidaemia Ð factor 1, Table 3 , three-factor models).
Two previous factor analyses have investigated the role of uric acid in the Metabolic Syndrome. In 50 non-diabetic subjects, uric acid loaded on one of two factors identi®ed. 26 This factor also contained loadings by blood pressure, lipid abnormalities, waist circumference and insulin resistance measured using the hyperinsulinemic euglycemic clamp. The previously mentioned analysis that incorporated leptin revealed a high uric acid loading (0.61) on a factor also associated with leptin, glucose intolerance, BMI, blood pressure and greater central skinfold thickness. 13 Other correlational analyses have demonstrated associations between uric acid and features of the Metabolic Syndrome taken singly 27 or in clusters, 28 but a consistent role for uric acid in this entity is not apparent from previous research.
The present analysis suggests an association between uric acid and underlying pathophysiologic events responsible for abnormal lipid levels in women and higher blood pressure in men. Mechanisms for this are largely unknown. Uric acid may be elevated as a side-effect of decreased renal clearance associated with hyperinsulinaemia, 29 or due to an error in the glycolytic pathway also resulting in insulin resistance and elevated triglyceride concentration. 30 Other factor analyses of the Metabolic Syndrome have been performed. Edwards et al identi®ed three factors in a group of women. 18 The ®rst, comparable with the central metabolic factor minus dyslipidaemia, consisted of obesity and elevated fasting insulin and glucose; the second, elevated fasting and post-load insulin and glucose was comparable with the glucose intolerance factor; and the third was dyslipidaemia, with reduced LDL peak particle diameter, and HDL-cholesterol and elevated triglycerides. 18 If both systolic and diastolic blood pressure were included in the factor analysis, a separate hypertension factor was also identi®ed. 18 The Strong Heart Study conducted in American Indians identi®ed three factors in non-diabetic subjects: glucosea obesityahyperinsulinaemia, blood pressure, and dyslipidaemia. 31 These somewhat contrasting results re¯ect differences in the methodology and populations studied in comparison to our results from Mauritius and in the Framingham population. 17 The separation of hypertension and insulin levels in factor analysis is consistent with previous studies in non-diabetic Mauritians showing that blood pressure was not associated with insulin after adjusting for age and BMI in crosssectional analysis. 32 Using the entire sample from the 1987 The fasting and 2 h insulin concentrations differed in their factor loading patterns. The 2 h value was more strongly related with factor 3, characterized by high glucose loadings. The fasting insulin concentration loaded more strongly on factor 1, although 2 h insulin also loaded on this factor in men and women. It is not clear why fasting insulin was not as important as 2 h insulin in the glucose intolerance factor, but this observation agrees with that of Meigs et al, 17 who suggest that elevated 2 h insulin re¯ects both peripheral insulin resistance and inadequate early insulin response. 2 Fasting insulin on the other hand, was more closely related to factor 1, characterized by adiposity, lipid levels and leptin. Fasting insulin is closely correlated with insulin resistance as measured by clamp studies, and is generally considered to be the better marker of insulin resistance for epidemiologic studies. 34 On this basis, insulin resistance appears to be characteristic of the cluster of obesity and dyslipidaemia in Mauritius and the Framingham Offspring, 17 but aetiological associations between insulinaemia, insulin resistance, obesity, glucose intolerance and dyslipidaemia cannot be inferred from our results.
The lack of overlap of BMI and WHR between factors was unexpected, as both have been associated with hypertension, 35 speci®cally in Asian Indians, and with glucose intolerance, 36 and were correlated with blood pressure and glucose levels within the study sample. In our population, a moderately high factor loading (0.39) was seen for WHR on the blood pressure factor (factor 2) among men only. In the Framingham Offspring Study, BMI overlapped between the hypertension and central Metabolic Syndrome factors. In a recent study Liese et al 37 showed that fasting insulin, BMI and WHR predicted with similar strength the incidence of type 2 diabetes mellitus, hypertension and dyslipidaemia in isolation or combined, over a 3 y follow-up. These three risk factors appeared to have at least additive, independent effects on the risk of these outcomes.
In conclusion, this analysis has identi®ed three separate factors within the Metabolic Syndrome among Mauritians. This suggests that three separate physiological pathways underlie this condition. Overall, few variables loaded on more than one factor. Among men and women, both fasting and 2 h insulin loaded on more than one factor and, among women, fasting glucose only. A key role for any of these variables in the Metabolic Syndrome is therefore unlikely, although, on the basis of this analysis, insulin level and possibly its correlates (insulin resistance) would be the chief candidates. Leptin did not appear to have a major role linking various components of the Metabolic Syndrome, although it was strongly associated with obesity measures, insulinaemia, and lipid levels, and can be included in the Metabolic Syndrome on statistical grounds at least.
